Geranylgeranylpyrophosphate, a metabolite of mevalonate, regulates the cell cycle progression and DNA synthesis in human lymphocytes

Biochemical and Biophysical Research Communications
Ichiro TatsunoA Hirai

Abstract

We investigated the role of the intrinsic mevalonate cascade in DNA synthesis and cell cycle progression in human peripheral blood mononuclear cells (PBMC) stimulated by phytohemagglutinin (PHA). PHA stimulated the expression of 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase mRNA prior to the DNA synthesis (S phase). Pravastatin, an HMG-CoA reductase inhibitor, inhibited DNA synthesis and blocked the entry to S phase in PHA-stimulated PBMC. Mevalonate restored these inhibitory effects. Thus, we examined two major metabolites of mevalonate, geranylgeranyl-pyrophosphate (GGPP) and farnesyl-pyrophosphate (FPP), using a novel liposome system for uptake into the cells. GGPP, not FPP, restored the pravastatin-induced inhibitions. These data indicated that 1) the intrinsic mevalonate cascade plays critical roles for the entry to S phase and DNA synthesis, and that 2) GGPP is an essential metabolite of mevalonate cascade for cell cycle progression in PBMC stimulated by PHA.

Citations

Jan 13, 2006·Neurobiology of Disease·S L Cole, R Vassar
Mar 16, 2002·European Journal of Biochemistry·Yajaira SuárezMiguel A Lasunción
Feb 3, 2005·Journal of Lipid Research·Carlos FernándezMiguel A Lasunción
Dec 24, 2014·Journal of Dental Research·Y NagaokaK Okabe
Jan 19, 2000·Circulation·D J MaronM F Linton
Jun 15, 2007·American Journal of Physiology. Heart and Circulatory Physiology·Mansoor Mozayan, Tony J F Lee
Mar 21, 2003·Biochemical and Biophysical Research Communications·Renu WadhwaSunil C Kaul
Jul 30, 2003·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Anu TöyräsJukka Mönkkönen
Apr 18, 2020·Molecular Therapy. Methods & Clinical Development·Ying GongWilfred T V Germeraad

❮ Previous
Next ❯

Related Concepts

Related Feeds